Atomoxetine and oxybutynin (ato-oxy)

DRUG2 trials

Sponsors

University of Arizona

Conditions

Down SyndromeObstructive Sleep Apnea

Phase 2

Medications for Obstructive Sleep Apnea In Children With Down Syndrome

CompletedNCT04115878

University of ArizonaDown Syndrome, Obstructive Sleep Apnea

Start: 2020-10-21End: 2022-12-30Updated: 2025-08-19

Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome

Active, not recruitingNCT05933603

University of ArizonaDown Syndrome, Obstructive Sleep Apnea

Start: 2023-09-29End: 2026-06-01Target: 36Updated: 2026-04-07

Related Papers

The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.

2023-12-018 citations